Enzene Biosciences
Fast Facts
Location: Hopewell
Industry: Life Sciences
Country of Origin: India
Type of Facility: Manufacturing Plant
Enzene Biosciences, Ltd., an India-based biopharmaceutical CDMO, opened its state-of-the-art manufacturing plant on the Princeton West Innovation Campus in Hopewell, New Jersey, in September 2025. Enzene invested about $50 million to create this new facility. The establishment of this plant not only underscores the growing significance of New Jersey in the biotech sector but also highlights the state’s commitment to fostering innovation and economic growth.
The successful engagement with Enzene began during a business attraction mission to India in 2022, organized by Choose New Jersey. The organization’s efforts were pivotal in connecting Enzene with vital in-state partners, including construction firms, business insurance providers, local leadership, and academic institutions. This collaborative approach has facilitated Enzene’s entry into the New Jersey market and showcases the state’s strategic advantages, including a robust talent pool and an ecosystem conducive to biotech advancements. With Enzene’s investment, New Jersey continues to solidify its reputation as a premier destination for biotechnology and pharmaceutical innovation.
Translate